When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Sofosbuvir/velpatasvir - Wikipedia

   en.wikipedia.org/wiki/Sofosbuvir/velpatasvir

   Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [2] [5] [6] [7] It combines sofosbuvir and velpatasvir. [2] [5] [6] It is more than 90% effective for hepatitis C genotypes one through six. [2]

3. Ledipasvir - Wikipedia

   en.wikipedia.org/wiki/Ledipasvir

   Ledipasvir is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. [1] After completing Phase III clinical trials, on February 10, 2014, Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C. [2] [3] The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication ...

4. Hepatitis C - Wikipedia

   en.wikipedia.org/wiki/Hepatitis_C

   There is no vaccine against hepatitis C. [1] [9] Prevention includes harm reduction efforts among people who inject drugs, testing donated blood, and treatment of people with chronic infection. [ 4 ] [ 10 ] Chronic infection can be cured more than 95% of the time with antiviral medications such as sofosbuvir or simeprevir .

5. Here's What Hepatitis C Actually Is—and How You Get It - AOL

   www.aol.com/lifestyle/heres-hepatitis-c-actually...

   In all cases, after just 12 weeks of treatment, 95 percent of people diagnosed with hepatitis C are cured. How to Prevent Hepatitis C Cured of hepatitis C, however, doesn’t mean immune.

6. What People Who Inject Drugs Should Know about Hepatitis C ...

   www.aol.com/people-inject-drugs-know-hepatitis...

   Hepatitis C treatment guidelines also vary based on whether you have cirrhosis (scarring of the liver) and how severe it is. Related: 15 Celebrities With Hepatitis C, from Natasha Lyonne to David ...

7. Ledipasvir/sofosbuvir - Wikipedia

   en.wikipedia.org/wiki/Ledipasvir/sofosbuvir

   Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. [8] It is a fixed-dose combination of ledipasvir and sofosbuvir. [8] Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. [9] Some evidence also supports use in HCV genotype 3 and 4. [9]